Key result
Cardiovascular risk scores had equal value in predicting subclinical atherosclerosis (IMT and CDist) in young adults, with AUCs for high IMT ranging from 0.712 to 0.733 (P≥0.15 vs Framingham).
Why the study?
Do cardiovascular risk scores accurately predict subclinical atherosclerosis in healthy young adults?
Cohort (n=2,204)
Do cardiovascular risk scores accurately predict subclinical atherosclerosis in healthy young adults?
Effect estimate: AUC 0.733 (Finrisk), 0.726 (SCORE), 0.712 (PROCAM), 0.729 (Reynolds) vs 0.728 (Framingham)
p-value: p=≥0.15
Various cardiovascular risk scores have similar predictive value for subclinical atherosclerosis (IMT and CDist) in young adults, though SCORE was slightly better for predicting low FMD.
Risk scores show comparable moderate accuracy for subclinical atherosclerosis in young adults; hypothesis-generating and should not yet change practice.
AIM: To study the utility of risk scores in the prediction of subclinical atherosclerosis in young adults. METHODS AND RESULTS: Participants were 2204 healthy Finnish adults aged 24-39 years in 2001 from a population-based follow-up study Cardiovascular Risk in Young Finns. We examined the performance of the Framingham, Reynolds, Systematic Coronary Risk Evaluation (SCORE), PROCAM, and Finrisk cardiovascular risk scores to predict subclinical atherosclerosis, that is carotid artery intima-media thickness (IMT) and plaque, carotid artery distensibility (CDist), and brachial artery flow-mediated dilatation (FMD) 6 years later. In a 6-year prediction of high IMT (highest decile or plaque), areas under the receiver operating characteristic curves (AUC) for baseline Finrisk (0.733), SCORE (0.726), PROCAM (0.712), and Reynolds (0.729) risk scores were similar as for Framingham risk score (0.728, P always ≥0.15). All risk scores had a similar discrimination in predicting low CDist (lowest decile) (0.652, 0.642, 0.639, 0.658, 0.652 respectively, P always ≥0.41). In the prediction of low FMD (lowest decile), Finrisk, PROCAM, Reynolds, and Framingham scores had similar AUCs (0.578, 0.594, 0.582, 0.568, P always ≥0.08) and SCORE discriminated slightly better (AUC=0.596, P<0.05). The prediction of subclinical outcomes was consistent when estimated from other statistical measures of discrimination, reclassification, and calibration. CONCLUSION: Cardiovascular disease risk scores had equal value in predicting subclinical atherosclerosis measured by IMT and CDist in young adults. SCORE was more accurate in predicting low FMD than Framingham risk score.
No takes yet. Share an insight, caveat, or question.
Raiko et al. (2010) conducted a cohort in Healthy adults (subclinical atherosclerosis prediction) (n=2,204). Cardiovascular risk scores (Finrisk, SCORE, PROCAM, Reynolds) vs. Framingham risk score was evaluated on High carotid artery intima-media thickness (IMT) or plaque (AUC 0.733 (Finrisk), 0.726 (SCORE), 0.712 (PROCAM), 0.729 (Reynolds) vs 0.728 (Framingham), p=≥0.15). Cardiovascular risk scores had equal value in predicting subclinical atherosclerosis (IMT and CDist) in young adults, with AUCs for high IMT ranging from 0.712 to 0.733 (P≥0.15 vs Framingham).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: